SEC's 'Shadow Trading' Test Case Fails Miserably, Court Told
The former pharmaceutical executive at the center of the U.S. Securities and Exchange Commission's first "shadow trading" case said Thursday that he was the wrong guy to test the novel insider...To view the full article, register now.
Already a subscriber? Click here to view full article